Sustaining excellence: The evolving role of quality in pharma

In the ever-evolving landscape of the pharma industry, the pursuit of quality remains a cornerstone of success. As stringent regulatory frameworks, rising patient expectations, and the increasing pace of innovation, transforms the pharma industry, the definition of quality is also evolving. From ensuring compliance with global standards to embracing cutting-edge technologies like Al-driven quality control, the industry is navigating a paradigm shift in how it approaches product integrity, safety, and efficacy. In this New Year issue, pharma experts explore how crucial it is to foster a culture of quality across organisations and deliver better healthcare outcomes

- 

Quality leaders will need to foster a culture of continuous learning

Quality management in pharmaceutical industry is critical to ensuring the safety, efficacy, and consistency of drugs. However, there are several challenges that pharma companies face in maintaining high-quality standards.

Regulatory compliance and evolving standards: Regulations imposed by authorities such as the FDA, EMA, and other national regulatory bodies are frequently updated, requiring constant monitoring and adaptation. Ensuring that all products meet required standards at every stagefrom development to postmarket surveillance can be time-consuming and costly.

Non-compliance can result in severe penalties, recalls, and damage to a company's reputation. Important is patient centricity during development, manufacturing and quality monitoring.

Data integrity and documentation: Need for accurate and reliable data is paramount. Regulatory bodies require strict documentation and data tracking without any discrepancies. With increasing use of digital technologies and automation, ensuring integrity and traceability of data becomes more complex. Poor data management can lead to regulatory fines, delays in approval processes, and compromised product quality.

Supply chain complexity: Supply chain is intricate, involving multiple suppliers, manufacturers, and distribution channels. Variability in raw material quality, supply chain disruptions and counterfeit drugs are persistent concerns. Any interruption or failure in the supply chain can affect quality of final product, leading to shortages or quality issues.